1
-
7
of
7
results (0.33 seconds)
Sort By:
-
Biosimilars, Part 6: Maximizing Adoption
Biosimilars, Part 6: Maximizing Adoption The coming wave of biosimilars could have a major impact on prescription drug spend in coming years. The big event of Humira biosimilar launches in 2023 ...- Authors: Tony Pistilli, Greg Warren
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability
-
Biosimilars, Part 3: Humira Biosimilar Launches
Biosimilars, Part 3: Humira Biosimilar Launches The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
2022-biologic-drugs
Develop a better understanding of specialty drug trends and their increasing healthcare costs for more than the past decade by attending this webcast. With the introduction of price competition, ...- Authors: Tony Pistilli, Greg Warren
- Date: Jul 2023
- Competency: External Forces & Industry Knowledge; Results-Oriented Solutions; Strategic Insight and Integration
- Topics: Health & Disability; Public Policy
-
Biosimilars, Part 4: The Financial Impact
Biosimilars, Part 4: The Financial Impact Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can ...- Authors: Greg Warren, Tony Pistilli
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Biosimilars, Part 5: Payer Decision Making
Biosimilars, Part 5: Payer Decision Making The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many ...- Authors: Greg Warren, Tony Pistilli
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Chronic health management - Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance
-
healthcare-sharing-ministries
Learn more about Health Care Sharing Ministries (HCSMs) and their functionality as health insurance. These nonprofit companies pool money from participating members to assist with members' ...- Authors: Tony Pistilli, Rob Nordstrom, Scott Reddig, Joshua Axene
- Date: Feb 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Topics: Health & Disability; Public Policy
-
Biosimilars, Part 1: A Brief Introduction
Biosimilars, Part 1: A Brief Introduction What are Biosimilar drugs? Are they the same as generic drugs? What potential impact might Biosimilars have in the United States prescription drug ...- Authors: Gregory Warren, Tony Pistilli
- Date: Sep 2023
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability